Proven Healthy Weight Loss Diet

Gene Smart is one of the very few wellness or diet programs that have been validated in a clinical study.

In addition, each individual diet and exercise strategy in the Gene Smart program has been substantiated through clinical trials from major medical institutions and published in the leading peer-reviewed scientific journals.

Dr. Chilton’s own laboratory recently completed an eight-week long observational study on 59 individuals who participated in the Gene Smart Program. The study was among  the most comprehensive of its kind, measuring the impact of the program on over 150 markers including biochemical, gene expression, physical, and emotional & quality of life measurements.

The data from this observational study and other studies provide convincing evidence that the Gene Smart Diet can help you take control of your health.  Here are some of the results:

Weight Loss

Those in the Gene Smart study lost 1½ to 2 pounds, ½-inch around their waists, and almost 0.5 percent of their body fat per week. These are averages, of course, but they’re pretty amazing. They reflect a pace of weight loss that’s healthy and safe.

What’s more, sticking with Gene Smart wasn’t hard. Unlike conventional weight-loss diets, the majority of our study participants reported no hunger, no confusion, and no problems with compliance. They enjoyed their meals, and they felt full and satisfied after eating.  Impressively, over 90% of our Gene Smart clinical test participants stayed on the program until the very end, a rate of success that is three times higher, or more, of a typical weight loss program.  Even more, 74% of this group maintained their weight loss, or continued to lose, a full 10 weeks after we concluded the study, the last time we measured.

Heart Health

Heart disease is the leading cause of death in the United States. In their 8 weeks on Gene Smart, our test panelists saw reductions in their triglycerides (20 mg/dl, on average), LDL cholesterol (10 mg/dl), blood pressure, and resting heart rate. The degree of change depended largely on each person’s initial readings. The good news is, those with the most significant risk factors saw the greatest improvements.  Similarly, leading biomarkers of inflammation—including leptin and interleukin-6—declined over the 8 weeks of Gene Smart. Leptin, the pro-inflammatory protein produced by fat cells, dropped by a staggering 35 percent.

Diabetes

An estimated 23.6 million Americans—a mind-blowing 7.8 percent of the population—have some form of diabetes.

The Gene Smart study group showed marked reductions in hemoglobin A1c, HOMA (a critical indicator of insulin resistance), and SCD1, among other biomarkers of insulin resistance and diabetes. Most impressively, Gene Smart reduced fasting insulin levels by more than 30 percent. A high fasting insulin is a sign of insulin resistance and the onset of metabolic syndrome or type 2 diabetes.

Between 50 and 75 million Americans have metabolic syndrome, defined by the American Heart Association (AHA) as the presence of three or more risk factors, including abdominal obesity; high triglycerides or cholesterol; elevated blood pressure; and abnormal insulin or glucose levels. In the Gene Smart Study, the percentage of men who had metabolic syndrome was reduced from 57% to 29%, and the number of women from 39% to 23% over the eight weeks.

And More

The Gene Smart Program observational study will be the subject of several articles that will be published in leading peer reviewed scientific journals.  As the articles are published we will share additional study results.